Navitoclax,ruxolitinib 
AbbVie,Novartis
['ruxolitinib', '#myelof', 'rux,(-crux),(-trux),(-deruxtecan)', 'navitoclax', 'abbvie', '$abbv']
#abbvie presents data #ash22 for investigational #navitoclax in combination with #ruxolitinib for #jakinhibitor-na ve #myelofibrosis patients $abbv 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.